These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection]. Wang YD; Liang QF; Li ZY; Zhao CY Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324 [TBL] [Abstract][Full Text] [Related]
3. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases. Musunuru K J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331 [TBL] [Abstract][Full Text] [Related]
4. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research]. Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746 [TBL] [Abstract][Full Text] [Related]
5. The Future of Genome Editing. Cell; 2018 May; 173(6):1311-1313. PubMed ID: 29856947 [TBL] [Abstract][Full Text] [Related]
7. Genome Editing in Retinal Diseases using CRISPR Technology. Yiu G Ophthalmol Retina; 2018 Jan; 2(1):1-3. PubMed ID: 31047294 [No Abstract] [Full Text] [Related]
8. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges. Mout R; Ray M; Lee YW; Scaletti F; Rotello VM Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568 [TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cpf1: A New Tool for Plant Genome Editing. Zaidi SS; Mahfouz MM; Mansoor S Trends Plant Sci; 2017 Jul; 22(7):550-553. PubMed ID: 28532598 [TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases. Duroux-Richard I; Giovannangeli C; Apparailly F Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565 [No Abstract] [Full Text] [Related]
12. Genome Editing: A New Horizon for Oral and Craniofacial Research. Yu N; Yang J; Mishina Y; Giannobile WV J Dent Res; 2019 Jan; 98(1):36-45. PubMed ID: 30354846 [TBL] [Abstract][Full Text] [Related]
13. Development and application of CRISPR/Cas9 technologies in genomic editing. Zhang C; Quan R; Wang J Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822 [TBL] [Abstract][Full Text] [Related]
14. Delivery technologies for genome editing. Yin H; Kauffman KJ; Anderson DG Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020 [TBL] [Abstract][Full Text] [Related]
15. WHO sticks to 2020 governance plan for human-genome editing. Hamburg M; Cameron E Nature; 2019 Nov; 575(7782):287. PubMed ID: 31719697 [No Abstract] [Full Text] [Related]
16. CRISPR genome-editing: A medical revolution. Butler JR; Tector AJ J Thorac Cardiovasc Surg; 2017 Feb; 153(2):488-491. PubMed ID: 28104200 [No Abstract] [Full Text] [Related]
17. [Research progress of CRISPR-Cas9 system for gene therapy]. Zhan C; Xia X Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208 [TBL] [Abstract][Full Text] [Related]
18. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans]. Meng X; Zhou H; Xu S Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717 [TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 technology as a potent molecular tool for gene therapy. Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727 [TBL] [Abstract][Full Text] [Related]
20. New gene editing technique CRISPR-Cas9 raises important ethical questions, says advisory body. Hawkes N BMJ; 2016 Sep; 354():i5318. PubMed ID: 27694221 [No Abstract] [Full Text] [Related] [Next] [New Search]